172 related articles for article (PubMed ID: 10225726)
1. Ability to remove immunoglobulins and antiganglioside antibodies by double filtration plasmapheresis in Guillain-Barré syndrome: is it equivalent to plasma exchange?
Tagawa Y; Yuki N; Hirata K
Ther Apher; 1997 Nov; 1(4):336-9. PubMed ID: 10225726
[TBL] [Abstract][Full Text] [Related]
2. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
Tagawa Y; Yuki N
Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
[TBL] [Abstract][Full Text] [Related]
3. Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption.
Tagawa Y; Yuki N; Hirata K
J Neurol Sci; 1998 Apr; 157(1):90-5. PubMed ID: 9600682
[TBL] [Abstract][Full Text] [Related]
4. Two patients with acute Guillain-Barré syndrome treated with different apheresis methods.
Uetakagaito M; Horikawa H; Yoshinaka H; Tagawa Y; Yuki N
Ther Apher; 1997 Nov; 1(4):340-2. PubMed ID: 10225727
[TBL] [Abstract][Full Text] [Related]
5. Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
Lyu RK; Chen WH; Hsieh ST
Ther Apher; 2002 Apr; 6(2):163-6. PubMed ID: 11982959
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of anti-glycolipid antibody-associated neuropathy].
Yuki N
Rinsho Shinkeigaku; 1999 Dec; 39(12):1232-4. PubMed ID: 10791085
[TBL] [Abstract][Full Text] [Related]
8. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
[TBL] [Abstract][Full Text] [Related]
9. [Removal ability of anti-ganglioside antibodies in immunoadsorption using a modified tryptophan-immobilized column].
Tagawa Y; Yuki N; Hirata K
Rinsho Shinkeigaku; 1997 Oct; 37(10):863-7. PubMed ID: 9490893
[TBL] [Abstract][Full Text] [Related]
10. [Apheresis therapy in Guillain-Barré syndrome].
Nagayama H; Katayama Y
Nihon Rinsho; 2008 Jun; 66(6):1195-9. PubMed ID: 18540370
[TBL] [Abstract][Full Text] [Related]
11. Dissociation between titer of anti-ganglioside antibody and severity of symptoms in a case of Guillain-Barré syndrome with treatment-related fluctuation.
Inoue N; Kunishige M; Yoshida S; Oshima Y; Ohnishi Y; Kuroda Y; Asano A; Yoshino H; Matsumoto T; Mitsui T
J Neurol Sci; 2003 Jun; 210(1-2):105-8. PubMed ID: 12736098
[TBL] [Abstract][Full Text] [Related]
12. Protocol of comparison of the effects of single plasma exchange and double filtration plasmapheresis on peripheral lymphocyte phenotypes in patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a monocentric prospective study with single-case experimental design.
Moranne O; Ion IM; Cezar R; Messikh Z; Prelipcean C; Chkair S; Thouvenot E; Tran TA; Corbeau P; Chevallier T
BMC Neurol; 2022 Aug; 22(1):293. PubMed ID: 35931957
[TBL] [Abstract][Full Text] [Related]
13. Minimal number of plasma exchanges needed to reduce immunoglobulin in Guillain-Barré syndrome.
Yuki N; Tagawa Y; Hirata K
Neurology; 1998 Sep; 51(3):875-7. PubMed ID: 9748046
[TBL] [Abstract][Full Text] [Related]
14. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
15. Experience of double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
Chen WH; Yeh JH; Chiu HC
J Clin Apher; 1999; 14(3):126-9. PubMed ID: 10540367
[TBL] [Abstract][Full Text] [Related]
16. [Plasmapheresis for Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Odaka M
Nihon Rinsho; 2004 May; 62 Suppl 5():491-5. PubMed ID: 15197970
[No Abstract] [Full Text] [Related]
17. Manual plasmapheresis in the treatment of Guillain-Barré syndrome.
de Zoysa NS; Jayaweera KK; Vaithianathan T
J Clin Apher; 1994; 9(2):147-50. PubMed ID: 7798165
[TBL] [Abstract][Full Text] [Related]
18. [Plasmapheresis in 2 children with Guillain-Barré syndrome].
Rotteveel JJ; Mullaart RA; Weemaes CM; van Empelen R
Tijdschr Kindergeneeskd; 1983 Apr; 51(2):57-62. PubMed ID: 6879585
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome].
Yamazaki M; Koh CS; Hanyu N; Sakai T; Inoue A; Yanagisawa N
Arerugi; 1995 Apr; 44(4):498-502. PubMed ID: 7598643
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the adsorption ability between tryptophan and modified tryptophan columns.
Odaka M; Yuki N; Hirata K
Ther Apher; 1997 Nov; 1(4):353-5. PubMed ID: 10225730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
